• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

测量头颈癌患者的合并症。

Measuring comorbidity in patients with head and neck cancer.

作者信息

Hall Stephen F, Rochon Paula A, Streiner David L, Paszat Lawrence F, Groome Patti A, Rohland Susan L

机构信息

Department of Otolaryngology, Queen's University, Kingston, Ontario, Canada.

出版信息

Laryngoscope. 2002 Nov;112(11):1988-96. doi: 10.1097/00005537-200211000-00015.

DOI:10.1097/00005537-200211000-00015
PMID:12439168
Abstract

BACKGROUND

Comorbidities are diseases or conditions that coexist with a disease of interest. The importance of comorbidities is that they can alter treatment decisions, change resource utilization, and confound the results of survival analysis.

OBJECTIVE

The objective of this study was to determine the best comorbidity index to use in survival analysis of patients with squamous cell carcinoma of the head and neck.

METHOD

Four validated indexes, with very different methodologies (i.e., the Charlson Index, the Cumulative Illness Rating Scale, the Kaplan-Feinstein Classification, the Index of Co-existent Disease), were tested using data from 379 unselected consecutive patients with complete 3-year follow-up from the Kingston Regional Cancer Center. Kaplan-Meier analysis and Cox Proportional Hazards Regression were used to stratify patients into three levels of increasing severity of comorbidity for each index. The Proportion of Variance Explained and Receiver Operating Characteristics curves were used to compare the performance of the indexes.

CONCLUSION

The Kaplan-Feinstein Classification was the most successful in stratifying patients in this population.

摘要

背景

合并症是与所关注疾病同时存在的疾病或状况。合并症的重要性在于它们会改变治疗决策、改变资源利用情况并混淆生存分析的结果。

目的

本研究的目的是确定在头颈部鳞状细胞癌患者生存分析中使用的最佳合并症指数。

方法

使用来自金斯顿地区癌症中心的379例未经选择的连续患者的数据,对四种经过验证的指数(即查尔森指数、累积疾病评分量表、卡普兰-费因斯坦分类法、共存疾病指数)进行了测试,这些指数的方法差异很大。使用卡普兰-迈耶分析和考克斯比例风险回归将患者按每个指数分为合并症严重程度递增的三个级别。使用方差解释比例和受试者工作特征曲线来比较各指数的性能。

结论

在对该人群患者进行分层方面,卡普兰-费因斯坦分类法最为成功。

相似文献

1
Measuring comorbidity in patients with head and neck cancer.测量头颈癌患者的合并症。
Laryngoscope. 2002 Nov;112(11):1988-96. doi: 10.1097/00005537-200211000-00015.
2
Comorbidity measurement in patients with laryngeal squamous cell carcinoma.喉鳞状细胞癌患者的共病测量
ORL J Otorhinolaryngol Relat Spec. 2007;69(3):146-52. doi: 10.1159/000099223. Epub 2007 Jan 30.
3
Comorbidity is a prognostic factor in elderly patients with head and neck cancer.合并症是老年头颈癌患者的一个预后因素。
Ann Surg Oncol. 2007 Apr;14(4):1449-57. doi: 10.1245/s10434-006-9296-1. Epub 2007 Jan 18.
4
Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer.查尔森合并症指数作为非小细胞肺癌手术后长期预后的预测指标。
Eur J Cardiothorac Surg. 2005 Nov;28(5):759-62. doi: 10.1016/j.ejcts.2005.06.046. Epub 2005 Sep 12.
5
The incidence and impact of comorbidity diagnosed after the onset of head and neck cancer.头颈部癌症发病后诊断出的合并症的发生率及影响。
Arch Otolaryngol Head Neck Surg. 2008 Oct;134(10):1045-9. doi: 10.1001/archotol.134.10.1045.
6
Interrater reliability of measurements of comorbid illness should be reported.应报告共病测量的评分者间信度。
J Clin Epidemiol. 2006 Sep;59(9):926-33. doi: 10.1016/j.jclinepi.2006.02.006. Epub 2006 Jun 23.
7
Measurement and impact of co-morbidity in elderly patients with advanced non-small cell lung cancer treated with chemotherapy. A phase II study of weekly paclitaxel.老年晚期非小细胞肺癌患者化疗时合并症的测量及其影响。每周一次紫杉醇的II期研究。
Acta Oncol. 2007;46(3):367-73. doi: 10.1080/02841860600833178.
8
Survival analysis of clear cell renal carcinoma according to the Charlson comorbidity index.根据查尔森合并症指数对透明细胞肾细胞癌进行生存分析。
J Urol. 2008 Mar;179(3):857-61. doi: 10.1016/j.juro.2007.10.048. Epub 2008 Jan 25.
9
Impact of comorbidity on short-term mortality and overall survival of head and neck cancer patients.共病对头颈部癌症患者短期死亡率和总生存率的影响。
Head Neck. 2010 Jun;32(6):728-36. doi: 10.1002/hed.21245.
10
Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice.皮肤型头颈部鳞状细胞癌伴淋巴结转移患者的手术及辅助放疗:联合治疗应被视为最佳治疗方案。
Laryngoscope. 2005 May;115(5):870-5. doi: 10.1097/01.MLG.0000158349.64337.ED.

引用本文的文献

1
Impact of pretreatment body mass index on the survival of head and neck cancer patients.治疗前体重指数对头颈部癌症患者生存的影响。
Head Neck. 2024 Aug;46(8):1881-1892. doi: 10.1002/hed.27659. Epub 2024 Jan 25.
2
Treatment Outcomes of Sinonasal Malignancies Involving the Orbit.累及眼眶的鼻窦恶性肿瘤的治疗结果
J Neurol Surg B Skull Base. 2021 May 29;83(Suppl 2):e430-e437. doi: 10.1055/s-0041-1730353. eCollection 2022 Jun.
3
How to Improve the Drafting of Health Profiles.如何提高健康档案的起草质量。
Int J Environ Res Public Health. 2022 Mar 15;19(6):3452. doi: 10.3390/ijerph19063452.
4
Low skeletal muscle mass as predictor of postoperative complications and decreased overall survival in locally advanced head and neck squamous cell carcinoma: the role of ultrasound of rectus femoris muscle.低骨骼肌量可预测局部晚期头颈部鳞状细胞癌术后并发症和总生存时间下降:股直肌超声的作用。
Eur Arch Otorhinolaryngol. 2020 Dec;277(12):3489-3502. doi: 10.1007/s00405-020-06123-3. Epub 2020 Jun 13.
5
Mechanisms of decision-making in preoperative assessment for older adult prostate cancer patients-A qualitative study.老年前列腺癌患者术前评估决策机制的定性研究。
J Surg Oncol. 2020 Mar;121(3):561-569. doi: 10.1002/jso.25819. Epub 2019 Dec 23.
6
The impact of comorbidity on overall survival in elderly nasopharyngeal carcinoma patients: a National Cancer Data Base analysis.共病对老年鼻咽癌患者总生存的影响:国家癌症数据库分析。
Cancer Med. 2018 Apr;7(4):1093-1101. doi: 10.1002/cam4.1377. Epub 2018 Mar 1.
7
Comorbidity in older adults with cancer.老年癌症患者的合并症。
J Geriatr Oncol. 2016 Jul;7(4):249-57. doi: 10.1016/j.jgo.2015.12.002. Epub 2015 Dec 22.
8
Morphomic analysis as an aid for preoperative risk stratification in patients undergoing major head and neck cancer surgery.形态学分析辅助头颈部癌症大手术患者的术前风险分层
J Surg Res. 2015 Mar;194(1):177-84. doi: 10.1016/j.jss.2014.10.002. Epub 2014 Oct 7.
9
comoR: a software for disease comorbidity risk assessment.comoR:一种用于疾病共病风险评估的软件。
J Clin Bioinforma. 2014 May 23;4:8. doi: 10.1186/2043-9113-4-8. eCollection 2014.
10
Survival of patients with head and neck cancer. Impact of physical status and comorbidities.头颈部癌症患者的生存情况。身体状况和合并症的影响。
Strahlenther Onkol. 2012 Jan;188(1):62-70. doi: 10.1007/s00066-011-0009-8. Epub 2011 Dec 23.